Cargando…

A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer

BACKGROUND: Pancreatic cancer (PAAD) is a malignant tumor with a poor prognosis and lacks sensitive biomarkers for diagnosis and targeted therapy. Cuproptosis, a recently proposed form of cell death based on cellular copper ion concentration, plays a key role in cancer biology. This study is aimed a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Yan, Jiang, Wenkai, Hou, Shuang, Chen, Zhou, Zhou, Wence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876676/ https://www.ncbi.nlm.nih.gov/pubmed/36714025 http://dx.doi.org/10.1155/2023/3419401

Ejemplares similares

Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer
por: Jiang, Wenkai, et al.
Publicado: (2022)

A novel cuproptosis-related gene signature to predict prognosis in Glioma
por: Zhang, Mengyang, et al.
Publicado: (2023)

A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer
por: Lei, Lei, et al.
Publicado: (2022)

A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
por: Zhang, Huizhe, et al.
Publicado: (2022)

Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma
por: Ye, Wei, et al.
Publicado: (2022)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023)

A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
por: Luo, Bixian, et al.
Publicado: (2022)

Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis
por: Shi, Huaqing, et al.
Publicado: (2023)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023)

Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis
por: Du, Yan, et al.
Publicado: (2023)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022)

A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

A cuproptosis-related signature for predicting the prognosis of gastric cancer
por: He, Chunmei, et al.
Publicado: (2023)

Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2023)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer
por: Wu, Lingfeng, et al.
Publicado: (2023)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer
por: Li, Jixian, et al.
Publicado: (2023)

Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer
por: Zhang, Jili, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
por: Chen, Jia, et al.
Publicado: (2022)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma
por: Yang, Weiguang, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
por: He, Fengjiao, et al.
Publicado: (2023)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
por: Liu, Xinyu, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

Characterization of a cuproptosis-related signature to evaluate immune features and predict prognosis in colorectal cancer
por: Li, Lei, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
por: Liu, Li, et al.
Publicado: (2023)

A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma
por: Luo, Lan, et al.
Publicado: (2022)

Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity
por: Huang, Xufeng, et al.
Publicado: (2022)

Neutrophils in pancreatic cancer: Potential therapeutic targets
por: Jiang, Wenkai, et al.
Publicado: (2022)

The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

The Global, Regional and National Burden of Pancreatic Cancer Attributable to Smoking, 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019
por: Jiang, Wenkai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91av09omqp4miik1t4sauao8op